ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BBC Virtus LifeSci Biotech Clinical Trials ETF

27.50
0.2315 (0.85%)
27 Nov 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Virtus LifeSci Biotech Clinical Trials ETF AMEX:BBC AMEX Exchange Traded Fund
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.2315 0.85% 27.50 27.75 27.37 27.48 2,272 22:12:30

Director Shareholding

13/11/2003 1:40pm

UK Regulatory


RNS Number:0397S
Ben Bailey PLC
13 November 2003



                       SCHEDULE 11

     NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED 
                        PERSONS


1)  NAME OF COMPANY

     BEN BAILEY PLC

2)  NAME OF DIRECTOR

     STEPHEN NORTH

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest

     AS 2 ABOVE

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)

     STEPHEN NORTH

5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)

      -

6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary

     EXERCISE OF OPTIONS

7)  Number of shares/amount of
    stock acquired

     25,000

8)  Percentage of issued Class

     0.21%

9)  Number of shares/amount
    of stock disposed



10) Percentage of issued Class



11) Class of security

     ORDINARY SHARES

12) Price per share

      43P

13) Date of transaction

     13 NOVEMBER 2003

14) Date company informed

     13 NOVEMBER 2003

15) Total holding following this notification

      25,000

16) Total percentage holding of issued class following this notification

      0.21%

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant



18) Period during which or date on which exercisable



19) Total amount paid (if any) for grant of the option



20) Description of shares or debentures involved: class, number.



21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise



22) Total number of shares or debentures over which options held
    following this notification



23) Any additional information



24) Name of contact and telephone number for queries



25) Name and signature of authorised company official responsible for
    making this notification  

    Date of Notification    13 NOVEMBER 2003                               



                      This information is provided by RNS
             The company news service from the London Stock Exchange

END

RDSUOAOROKRAAAA

1 Year Virtus LifeSci Biotech C... Chart

1 Year Virtus LifeSci Biotech C... Chart

1 Month Virtus LifeSci Biotech C... Chart

1 Month Virtus LifeSci Biotech C... Chart

Your Recent History

Delayed Upgrade Clock